<DOC>
	<DOCNO>NCT02294266</DOCNO>
	<brief_summary>The purpose study 1 ) evaluate pharmacological effect oral coadministration mephedrone alcohol 2 ) determine pharmacokinetics change mephedrone alcohol concentration oral coadministration mephedrone alcohol .</brief_summary>
	<brief_title>Mephedrone Alcohol Interactions Humans</brief_title>
	<detailed_description>Mephedrone ( 4-methylmetcathinone , 4-MMC ) new psychoactive substance ( NPS ) . Mephedrone frequently use combination alcohol . At present , effect interaction mephedrone alcohol humans previously evaluate randomize controlled clinical trial . The aim study 1 ) evaluate pharmacological effect oral coadministration mephedrone alcohol 2 ) determine pharmacokinetics change mephedrone alcohol concentration oral coadministration mephedrone alcohol .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Understanding accept study procedure sign informed consent . Male adults volunteer ( 1845 year old ) . Clinical history physical examination demonstrate organic psychiatric disorder . The ECG general blood urine laboratory test perform study within normal range . Minor occasional change normal range accept , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . These change nonrelevance justify write specifically . Recreational use amphetamine , ecstasy hallucinogen derivate , mephedrone cathinone least 6 occasion ( two previous year ) without adverse reaction . Recreational use alcohol ( ethanol ) . Previous experience acute alcohol intoxication . Extensive metabolizer intermediate metabolizer phenotype cytochrome P4502D6 ( CYP2D6 ) activity determine use dextromethorphan selective probe drug . The weight exceed 15 % ideal weight applies accord size 60 100 Kg . Minor variation accept normal limit , researcher consider clinically insignificant . Not meet inclusion criterion . Daily consumption &gt; 20 cigarette &gt; 4 standard unit ethanol . Regular use drug month prior study session . The treatment single limited dos symptomatic medicinal product week prior study session reason exclusion calculate cleared completely day experimental session . Presence major psychiatric disorder . Present history abuse drug dependence ( except nicotine dependence ) . Past history drug dependence ( except nicotine dependence ) . Past history drug abuse could include . Having suffer organic disease major surgery three month prior study start . Blood donation 12 week participation clinical trial drug previous 4 week . Subjects intolerance serious adverse reaction drug amphetamine , ecstasy hallucinogen derivate , mephedrone cathinone . History clinical evidence gastrointestinal , liver , renal disorder may lead suspect disorder drug absorption , distribution , metabolism excretion , suggest gastrointestinal irritation due drug . Subjects unable understand nature , consequence study procedure request follow . Subjects positive serology Hepatitis B , C HIV .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>